Sun Pharmaceutical Industries And Ranbaxy (UK) v Commission: ECFI 8 Sep 2016

ECJ (Judgment) Competition – Agreements, decisions and concerted practices – Market for antidepressant medicinal products containing the active pharmaceutical ingredient citalopram – Concept of restriction of competition by object – Potential competition – Generic medicinal products – Barriers to market entry resulting from the existence of patents – Agreement concluded between a patent holder and a generic undertaking – Fines – Legal certainty – Principle that penalties must have a proper legal basis – 2006 Guidelines on the method of setting fines – Duration of the Commission’s investigation

T-460/13, [2016] EUECJ T-460/13, ECLI:EU:T:2016:453

European, Commercial

Updated: 22 January 2022; Ref: scu.569063